Requirement for Rac1 in a K-ras induced lung cancer in the mouse
- PMID: 17804720
- DOI: 10.1158/0008-5472.CAN-07-2300
Requirement for Rac1 in a K-ras induced lung cancer in the mouse
Abstract
Given the prevalence of Ras mutations in human cancer, it is critical to understand the effector pathways downstream of oncogenic Ras leading to transformation. To directly assess the requirement for Rac1 in K-ras-induced tumorigenesis, we employed a model of lung cancer in which an oncogenic allele of K-ras could be activated by Cre-mediated recombination in the presence or absence of conditional deletion of Rac1. We show that Rac1 function is required for tumorigenesis in this model. Furthermore, although Rac1 deletion alone was compatible with cell viability and proliferation, when combined with K-ras activation in primary epithelial cells, loss of Rac1 caused a profound reduction in proliferation. These data show a specific requirement for Rac1 function in cells expressing oncogenic K-ras.
Similar articles
-
Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.PLoS One. 2015 Jun 1;10(6):e0127923. doi: 10.1371/journal.pone.0127923. eCollection 2015. PLoS One. 2015. PMID: 26030593 Free PMC article.
-
The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.Oncogene. 2013 Feb 14;32(7):903-9. doi: 10.1038/onc.2012.99. Epub 2012 Mar 19. Oncogene. 2013. PMID: 22430205 Free PMC article.
-
K-Ras mediated murine epidermal tumorigenesis is dependent upon and associated with elevated Rac1 activity.PLoS One. 2011 Feb 15;6(2):e17143. doi: 10.1371/journal.pone.0017143. PLoS One. 2011. PMID: 21358804 Free PMC article.
-
Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.Cancer Metastasis Rev. 2010 Mar;29(1):49-60. doi: 10.1007/s10555-010-9209-4. Cancer Metastasis Rev. 2010. PMID: 20108024 Review.
-
Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters.Exp Lung Res. 2000 Dec;26(8):709-30. doi: 10.1080/01902140150216774. Exp Lung Res. 2000. PMID: 11195466 Review.
Cited by
-
Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.PLoS One. 2015 Jun 1;10(6):e0127923. doi: 10.1371/journal.pone.0127923. eCollection 2015. PLoS One. 2015. PMID: 26030593 Free PMC article.
-
Regulation of lung cancer metastasis by Klf4-Numb-like signaling.Cancer Res. 2013 Apr 15;73(8):2695-705. doi: 10.1158/0008-5472.CAN-12-4232. Epub 2013 Feb 25. Cancer Res. 2013. PMID: 23440423 Free PMC article.
-
FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma.Cell Rep. 2021 Nov 2;37(5):109905. doi: 10.1016/j.celrep.2021.109905. Cell Rep. 2021. PMID: 34731623 Free PMC article.
-
Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.Genes Dev. 2014 Mar 15;28(6):561-75. doi: 10.1101/gad.233627.113. Epub 2014 Mar 3. Genes Dev. 2014. PMID: 24589553 Free PMC article.
-
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression.J Clin Invest. 2012 Sep;122(9):3170-83. doi: 10.1172/JCI63608. Epub 2012 Aug 1. J Clin Invest. 2012. PMID: 22850877 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous